The Insight Partners Latest Research for Report “Leukapheresis Market Forecast to 2028″ Focuses COVID-19 Impact and Global Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies and Hospitals and Transfusion Centers)
“Leukapheresis Market is projected to reach US$ 133.90 million by 2028 from US$ 74.48 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the leukapheresis market is primarily attributed to the rising number of voluntary blood donors, rising incidence of hematologic diseases, and the surging elderly population. However, the high cost of leukapheresis obstructs the growth of the market to a certain extent.
Download PDF Sample Copy at:
Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.
Leukapheresis market is segmented on the basis of product type, application and end user.
Based on product type, the leukapheresis market is bifurcated into leukapheresis devices and leukapheresis disposables. In 2021, the leukapheresis disposables segment held a larger share of the market. However, the leukapheresis devices segment is expected to register a higher CAGR during 2021–2028.
By application, the market is bifurcated into research applications and therapeutic applications.
Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, blood component providers and blood centers and hospitals and transfusion centers.
Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
Inquire Your Queries at:
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.
Top Companies are:
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
Buy Report at:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi